mhurhangee/patent-ind-claim-en huggingface dataset:
A trainer for cricothyrotomy, the trainer comprising: a case ; and a model of a patient mounted within the case, the model comprising: a hyoid analogue ; a thyroid analogue adjacent to the hyoid analogue; a cricoid analogue adjacent to the thyroid analogue; a tracheal analogue adjacent to the cricoid analogue; and a skin analogue adapted to cover the hyoid, thyroid, cricoid, and tracheal analogues CHARACTERISED IN THAT : the case comprises a base and a cover , wherein the base and the cover are slidably interconnected to enable the cover to slide relative to the base to expose the model; and the hyoid, thyroid, and cricoid analogues have lateral mobility within the base representing side-to-side mobility of the patient's larynx with or without the skin analogue applied to the hyoid, thyroid, and cricoid analogues. a case ; and a model of a patient mounted within the case, the model comprising: a hyoid analogue ; a thyroid analogue adjacent to the hyoid analogue; a cricoid analogue adjacent to the thyroid analogue; a tracheal analogue adjacent to the cricoid analogue; and a skin analogue adapted to cover the hyoid, thyroid, cricoid, and tracheal analogues CHARACTERISED IN THAT : the case comprises a base and a cover , wherein the base and the cover are slidably interconnected to enable the cover to slide relative to the base to expose the model; and the hyoid, thyroid, and cricoid analogues have lateral mobility within the base representing side-to-side mobility of the patient's larynx with or without the skin analogue applied to the hyoid, thyroid, and cricoid analogues. a hyoid analogue ; a thyroid analogue adjacent to the hyoid analogue; a cricoid analogue adjacent to the thyroid analogue; a tracheal analogue adjacent to the cricoid analogue; and a skin analogue adapted to cover the hyoid, thyroid, cricoid, and tracheal analogues CHARACTERISED IN THAT : the case comprises a base and a cover , wherein the base and the cover are slidably interconnected to enable the cover to slide relative to the base to expose the model; and the hyoid, thyroid, and cricoid analogues have lateral mobility within the base representing side-to-side mobility of the patient's larynx with or without the skin analogue applied to the hyoid, thyroid, and cricoid analogues. the case comprises a base and a cover , wherein the base and the cover are slidably interconnected to enable the cover to slide relative to the base to expose the model; and the hyoid, thyroid, and cricoid analogues have lateral mobility within the base representing side-to-side mobility of the patient's larynx with or without the skin analogue applied to the hyoid, thyroid, and cricoid analogues.
Method for securing a component, in particular an insulating material, to a substrate, in particular to a wall or ceiling of a building, the method comprising: - providing a nail having a nail shank and a nail head , wherein the nail head has a head diameter which projects beyond the nail shank , - providing a fastening element having a plate for holding the component, a hollow shaft which projects from the plate and has a shaft bottom , and a sleeve , wherein the sleeve projects from the shaft bottom , - disposing the nail shank in the sleeve , - providing a driving-in element and a guide channel , wherein the guide channel has an internal diameter which exceeds the head diameter, - introducing the guide channel into the hollow shaft until the guide channel rests against the shaft bottom and the nail head and the sleeve are arranged in the guide channel in such a way that an encircling gap is formed between the nail head and the guide channel , - driving the driving-in element through the guide channel onto the nail head in order to move the nail in a driving direction to the substrate, - compressing the sleeve between the nail shank , the guide channel and the nail head while the nail moves toward the substrate, and - pushing part of the sleeve into the encircling gap between the nail head and the guide channel , - wherein the sleeve completely fills a cavity between the nail shank , the guide channel and the nail head during compression between the nail shank , the guide channel and the nail head . - providing a nail having a nail shank and a nail head , wherein the nail head has a head diameter which projects beyond the nail shank , - providing a fastening element having a plate for holding the component, a hollow shaft which projects from the plate and has a shaft bottom , and a sleeve , wherein the sleeve projects from the shaft bottom , - disposing the nail shank in the sleeve , - providing a driving-in element and a guide channel , wherein the guide channel has an internal diameter which exceeds the head diameter, - introducing the guide channel into the hollow shaft until the guide channel rests against the shaft bottom and the nail head and the sleeve are arranged in the guide channel in such a way that an encircling gap is formed between the nail head and the guide channel , - driving the driving-in element through the guide channel onto the nail head in order to move the nail in a driving direction to the substrate, - compressing the sleeve between the nail shank , the guide channel and the nail head while the nail moves toward the substrate, and - pushing part of the sleeve into the encircling gap between the nail head and the guide channel , - wherein the sleeve completely fills a cavity between the nail shank , the guide channel and the nail head during compression between the nail shank , the guide channel and the nail head .
A cooling apparatus for cooling a fluid by means of surface water, the cooling apparatus comprising: - at least one tube for containing and transporting the fluid in its interior, the exterior of the tube being in operation at least partially submerged in the surface water so as to cool the tube to thereby also cool the fluid, characterized in that - the cooling apparatus is adapted to receive at least one light source for producing light that hinders fouling, wherein, the at least one light source is dimensioned and positioned with respect to the tube so as to cast anti-fouling light over the tubes' exterior, wherein the cooling apparatus further comprises: - at least one lamella that is at least partly in contact with the tubes , wherein optionally the lamella is hollow, the interior space of the lamella being in direct communication with the tubes , and wherein optionally the lamella is formed as an integral whole with a number of sections of tube portions . - at least one tube for containing and transporting the fluid in its interior, the exterior of the tube being in operation at least partially submerged in the surface water so as to cool the tube to thereby also cool the fluid, characterized in that - the cooling apparatus is adapted to receive at least one light source for producing light that hinders fouling, - at least one lamella that is at least partly in contact with the tubes , wherein optionally the lamella is hollow, the interior space of the lamella being in direct communication with the tubes , and wherein optionally the lamella is formed as an integral whole with a number of sections of tube portions .
Use of rhamnolipids and/or sophorolipids for increasing coverage and/or for maintaining application properties in the course of storage of coating compositions.
A composition comprising an activated Factor V (FVa) protein comprising the following modifications: mutations Arg306Gln, Arg506Gln, Arg679Gln, His609Cys, Glu1691Cys, and Ser2183Ala, wherein said FVa protein is resistant to APC inactivation.
A robotic surgical instrument comprising: a shaft ; and an instrument interface at a proximal end of the shaft, the instrument interface comprising: an instrument interface element for driving a pair of driving elements (C1, C2), the instrument interface element displaceable over a displacement range, the pair of driving elements secured to the instrument interface element such that a displacement of the instrument interface element is transferred to the pair of driving elements; a tensioning mechanism for tensioning the pair of driving elements; wherein the robotic surgical instrument further comprises an articulation at a distal end of the shaft for articulating an end effector , the articulation driveable by the pair of driving elements, and the instrument interface further comprises an alignment mechanism for setting the displacement position of the instrument interface element to a predetermined alignment position when the end effector has a predetermined configuration, the alignment mechanism being independent of the tensioning mechanism, so that during setting of the displacement position of the instrument interface element, the instrument interface element is displaced to the predetermined alignment position without displacing the pair of driving elements. a shaft ; and an instrument interface at a proximal end of the shaft, the instrument interface comprising: an instrument interface element for driving a pair of driving elements (C1, C2), the instrument interface element displaceable over a displacement range, the pair of driving elements secured to the instrument interface element such that a displacement of the instrument interface element is transferred to the pair of driving elements; a tensioning mechanism for tensioning the pair of driving elements; wherein the robotic surgical instrument further comprises an articulation at a distal end of the shaft for articulating an end effector , the articulation driveable by the pair of driving elements, and an instrument interface element for driving a pair of driving elements (C1, C2), the instrument interface element displaceable over a displacement range, the pair of driving elements secured to the instrument interface element such that a displacement of the instrument interface element is transferred to the pair of driving elements; a tensioning mechanism for tensioning the pair of driving elements; wherein the robotic surgical instrument further comprises an articulation at a distal end of the shaft for articulating an end effector , the articulation driveable by the pair of driving elements, and the instrument interface further comprises an alignment mechanism for setting the displacement position of the instrument interface element to a predetermined alignment position when the end effector has a predetermined configuration, the alignment mechanism being independent of the tensioning mechanism, so that during setting of the displacement position of the instrument interface element, the instrument interface element is displaced to the predetermined alignment position without displacing the pair of driving elements.
A method of cleaning a filler , wherein at least one of COP (Cleaning out of Place) and SOP (Sterilizing out of Place) treatments is performed by spraying a predetermined working fluid from spray nozzles in a predetermined order within an aseptic chamber accommodated with a filler , when such at least one of the COP and SOP treatments is performed, the predetermined working fluid is blasted toward externally of the filler in the predetermined order while moving a movable spray nozzle opposing to the filler around the filler from an outer periphery thereof, characterized in that the movable spray nozzle is disposed to the inside of a circular pipe that surrounds the filler from the outer side thereof and that is coupled with a rod of an air-cylinder device , and the movable spray nozzle is reciprocally moved in a vertical direction along a filling nozzle in the filler together with the circular pipe by the actuation of the air-cylinder device , and wherein when at least one of CIP (Cleaning in Place) and SIP (Sterilizing in Place) treatments is performed with respect to a drink supplying pipe line supplying the drink to the filler in a state of the filler being stopped in operation, at least one of the COP and SOP treatments is performed in parallel with the above at least one of the treatments.
A collapsible guitar comprising a guiding device for guiding a first set of strings into place when the instrument is reassembled, wherein the strings are arranged such that it is not necessary to detach the strings from the instrument when disassembled or reassembled, wherein the guitar comprises a headstock and means for folding the headstock along the neck, and wherein the guitar comprises first and/or second means for guiding the strings of the first set of strings, wherein the first guiding means is adapted to pivot, relative to the headstock without lateral movement relative thereto to guide the strings into position relative to each other at the headstock.
A denture adhesive composition, comprising: a) at least one component comprising a C5 to C15 polyalkene present in the composition in an amount of from 30% to 50%wt based on the total weight of the composition; and b) a viscosity index improver selected from the group consisting of polymethacrylates, olefin copolymers, hydrogenated styrene-diene copolymers, styrene polyesters, rubber, polyvinylchloride, nylon, fluorocarbon, polyurethane prepolymer, polyethylene, polystyrene, polypropylene, acrylic resins, microcrystalline wax, elastomers, poly(alkyl fumarate co-vinyl acetate), alkylated polystyrene, poly(t-butyl styrene), and combinations thereof, wherein the viscosity index improver is present in an amount from 0.001% to 20.0%wt; wherein the composition comprises a denture adhesive component; wherein the denture adhesive component is selected from the group consisting of cellulose, poly(n-butyl vinyl ether), poly(styrene-co-maleic anhydride), starch, saccharide, polyethylene oxides, polyethylene glycols, polyvinyl alcohols, carrageenan, alginates, karaya gum, xanthan gum, guar gum, gelatin, algin, tragacanth, chitosan, acrylamide polymers, carboxypolymethylene, polyamines, polyquaternary compounds, polyvinylpyrrolidone, polylvinylalkylacrylates /maleic anhydride copolymers and salts thereof including mixed salts, polymeric acids, polymeric salts, polyhydroxy compounds, and combinations thereof; and wherein the denture adhesive component is present in an amount from 40% to 65% based on the total weight of the composition. a) at least one component comprising a C5 to C15 polyalkene present in the composition in an amount of from 30% to 50%wt based on the total weight of the composition; and b) a viscosity index improver selected from the group consisting of polymethacrylates, olefin copolymers, hydrogenated styrene-diene copolymers, styrene polyesters, rubber, polyvinylchloride, nylon, fluorocarbon, polyurethane prepolymer, polyethylene, polystyrene, polypropylene, acrylic resins, microcrystalline wax, elastomers, poly(alkyl fumarate co-vinyl acetate), alkylated polystyrene, poly(t-butyl styrene), and combinations thereof, wherein the viscosity index improver is present in an amount from 0.001% to 20.0%wt; wherein the composition comprises a denture adhesive component; wherein the denture adhesive component is selected from the group consisting of cellulose, poly(n-butyl vinyl ether), poly(styrene-co-maleic anhydride), starch, saccharide, polyethylene oxides, polyethylene glycols, polyvinyl alcohols, carrageenan, alginates, karaya gum, xanthan gum, guar gum, gelatin, algin, tragacanth, chitosan, acrylamide polymers, carboxypolymethylene, polyamines, polyquaternary compounds, polyvinylpyrrolidone, polylvinylalkylacrylates /maleic anhydride copolymers and salts thereof including mixed salts, polymeric acids, polymeric salts, polyhydroxy compounds, and combinations thereof; and wherein the denture adhesive component is present in an amount from 40% to 65% based on the total weight of the composition.
A method of detecting c-reactive protein in multiple liquid samples, comprising the steps of: (a) obtaining a probe having a first antibody immobilized on the tip of the probe, wherein the diameter of the tip surface is ≤ 5 mm; wherein the first antibody is a mouse monoclonal anti-human C-reactive protein antibody CRP30. (b) dipping the probe in a pre-read vessel comprising an aqueous solution having pH of 6.0-8.5 to pre-read the fluorescent signal of the probe tip; (c) dipping the probe tip into a sample vessel containing a liquid sample having an analyte of c-reactive protein; (d) dipping the probe tip into a reagent vessel containing a reagent solution comprising a second antibody conjugated with one or more fluorescent labels to form an immunocomplex among the analyte, the first antibody, and the second antibody on the probe tip, wherein the first antibody and the second antibody are antibodies against the analyte; (e) dipping the probe tip into a washing vessel containing a wash solution; (f) determining the analyte concentration in the first sample by measuring the fluorescent signal of the immunocomplex at the probe tip, subtracting the pre-read fluorescent signal of (b), and quantitating against a calibration curve; (g) dipping the probe tip in an acidic solution having pH about 1.0-4.0 to elute the immunocomplex from the probe tip; and (h) repeating steps (b)-(g) with a second liquid sample in a second sample vessel in a second cycle, whereby the analyte in multiple liquid samples is detected. (a) obtaining a probe having a first antibody immobilized on the tip of the probe, wherein the diameter of the tip surface is ≤ 5 mm; wherein the first antibody is a mouse monoclonal anti-human C-reactive protein antibody CRP30. (b) dipping the probe in a pre-read vessel comprising an aqueous solution having pH of 6.0-8.5 to pre-read the fluorescent signal of the probe tip; (c) dipping the probe tip into a sample vessel containing a liquid sample having an analyte of c-reactive protein; (d) dipping the probe tip into a reagent vessel containing a reagent solution comprising a second antibody conjugated with one or more fluorescent labels to form an immunocomplex among the analyte, the first antibody, and the second antibody on the probe tip, wherein the first antibody and the second antibody are antibodies against the analyte; (e) dipping the probe tip into a washing vessel containing a wash solution; (f) determining the analyte concentration in the first sample by measuring the fluorescent signal of the immunocomplex at the probe tip, subtracting the pre-read fluorescent signal of (b), and quantitating against a calibration curve; (g) dipping the probe tip in an acidic solution having pH about 1.0-4.0 to elute the immunocomplex from the probe tip; and (h) repeating steps (b)-(g) with a second liquid sample in a second sample vessel in a second cycle, whereby the analyte in multiple liquid samples is detected.
A sealed, autoclaved contact lens package comprising a sterile, unworn contact lens and a contact lens packaging solution comprising epsilon polylysine (εPLL), wherein the unworn contact lens exhibits reduced contamination from at least one microbe, wherein said reduced contamination is determined by a test where Pseudomonas aeruginosa (PA) is introduced to the lens during removal from the contact lens packaging solution and compared to a control contact lens packaged in an identical contact lens packaging solution but without said εPLL, and wherein the unworn contact less results in less than a two log kill of PA compared to the control contact lens when tested after 24 hours incubation with 10 4 CFU PA using an in vitro bioactivity assay, wherein the contact lens is a conventional hydrogel contact lens or silicone hydrogel contact lens, and wherein the sealed contact lens package comprises a plastic base member that comprises a cavity configured to retain the contact lens and the packaging solution, and a flange region extending outwardly around the cavity, and a removable foil attached to the flange region to provide the sealed contact lens package. wherein the unworn contact lens exhibits reduced contamination from at least one microbe, wherein said reduced contamination is determined by a test where Pseudomonas aeruginosa (PA) is introduced to the lens during removal from the contact lens packaging solution and compared to a control contact lens packaged in an identical contact lens packaging solution but without said εPLL, and wherein the unworn contact less results in less than a two log kill of PA compared to the control contact lens when tested after 24 hours incubation with 10 4 CFU PA using an in vitro bioactivity assay, wherein the contact lens is a conventional hydrogel contact lens or silicone hydrogel contact lens, and wherein the sealed contact lens package comprises a plastic base member that comprises a cavity configured to retain the contact lens and the packaging solution, and a flange region extending outwardly around the cavity, and a removable foil attached to the flange region to provide the sealed contact lens package.
A system comprising a bilayer of lipid molecules provided at the interface between a first droplet of a first aqueous solution in a hydrophobic medium, the first droplet comprising a layer of lipid molecules around the surface of the first aqueous solution, and containing a transcription/translation extract and a heterologous polynucleotide encoding a membrane polypeptide; and a second droplet of a second aqueous solution in the hydrophobic medium, the second droplet comprising a layer of lipid molecules around the surface of the second aqueous solution; wherein the bilayer contains an amphipathic polymer and the encoded membrane polypeptide. a bilayer of lipid molecules provided at the interface between a first droplet of a first aqueous solution in a hydrophobic medium, the first droplet comprising a layer of lipid molecules around the surface of the first aqueous solution, and containing a transcription/translation extract and a heterologous polynucleotide encoding a membrane polypeptide; and a second droplet of a second aqueous solution in the hydrophobic medium, the second droplet comprising a layer of lipid molecules around the surface of the second aqueous solution; wherein the bilayer contains an amphipathic polymer and the encoded membrane polypeptide.
A communications method, comprising: determining control information, wherein the control information comprises a first field, and a value of the first field is used to indicate a quantity of first frequency domain units, a first start frequency domain unit index, and a second start frequency domain unit index; and the quantity of first frequency domain units is a quantity of frequency domain units comprised in a first data channel, a second data channel, or a third data channel, the first start frequency domain unit index is a start frequency domain unit index of the second data channel, and the second start frequency domain unit index is a start frequency domain unit index of the third data channel; and sending the control information and the first data channel in a first time unit; wherein the determining control information comprises: determining the value of the first field based on the first start frequency domain unit index, the second start frequency domain unit index, the quantity of first frequency domain units, and a quantity of frequency domain units comprised in a sidelink resource pool. determining control information, wherein the control information comprises a first field, and a value of the first field is used to indicate a quantity of first frequency domain units, a first start frequency domain unit index, and a second start frequency domain unit index; and the quantity of first frequency domain units is a quantity of frequency domain units comprised in a first data channel, a second data channel, or a third data channel, the first start frequency domain unit index is a start frequency domain unit index of the second data channel, and the second start frequency domain unit index is a start frequency domain unit index of the third data channel; and sending the control information and the first data channel in a first time unit; wherein the determining control information comprises: determining the value of the first field based on the first start frequency domain unit index, the second start frequency domain unit index, the quantity of first frequency domain units, and a quantity of frequency domain units comprised in a sidelink resource pool.